Novelix Pharmaceuticals Ltd — Board Meeting, 12-02-2026: Board Meeting
12-02-2026 | 06:04 pm
12-02-2026 | 06:04 pm
Novelix Pharma's board approved Q3 & 9M results, with quarterly net profit at 100.44. It also allotted 23.2 lakh shares via preferential issue, raising ₹13.92 Cr, increasing paid-up capital to ₹19.94 Cr from ₹17.62 Cr.
No comments yet. Be the first to comment!
